Early Phase 1 Virus Clinical Trials
6 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–6 of 6 trials
Recruiting
Early Phase 1
Merck IIT: RRP Pembro and Lenvatinib
Pulmonary DiseaseRecurrent Respiratory PapillomatosisHuman Papilloma Virus
Yale University20 enrolled1 locationNCT04645602
Recruiting
Early Phase 1
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
Allogeneic Hematopoietic Stem Cell Transplantation RecipientAdenovirusCytomegalovirus+2 more
Sumithira Vasu20 enrolled2 locationsNCT03665675
Recruiting
Early Phase 1
A Study of APL-10456-Vaccine
Rhinovirus
Apollo Therapeutics Ltd144 enrolled1 locationNCT07399132
Recruiting
Early Phase 1
A Clinical Trial of SIBP-A16 Injection in Healthy Adults
Respiratory Syncytial Virus (RSV)
Shanghai Institute Of Biological Products140 enrolled1 locationNCT07106918
Recruiting
Early Phase 1
T Cell Therapy of Opportunistic Cytomegalovirus Infection
Hematopoietic Stem Cell TransplantCytomegalovirus InfectionsOpportunistic Infections
Mari Dallas20 enrolled1 locationNCT02982902
Recruiting
Early Phase 1
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
Cytomegalovirus RetinitisGanciclovir Eye Drops
Tianjin Medical University15 enrolled1 locationNCT05911503